The sulphoxidation of S-carboxymethyl-L-cysteine in COPD [5]

European Respiratory Journal

Volumn 27, Issue 4, 2006, Pages 865-866

  Steventon, G B ^a   Mitchell, S C ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOCISTEINE; DIOXYGENASE; MUCOLYTIC AGENT; PHENYLALANINE 4 MONOOXYGENASE; SCAVENGER; SULFIDE; SULFOXIDE; SULFUR; DRUG DERIVATIVE; EXPECTORANT AGENT; SAFROLE;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CIRCADIAN RHYTHM; DRUG DISPOSITION; DRUG EFFICACY; DRUG METABOLISM; DRUG TRANSFORMATION; DRUG USE; GENETIC POLYMORPHISM; HUMAN; INDIVIDUALIZATION; LETTER; OXYGENATION; PHARMACOGENETICS; PRIORITY JOURNAL; STANDARDIZATION; BIOTRANSFORMATION; CHRONOTHERAPY; TREATMENT OUTCOME;

BIOTRANSFORMATION; CARBOCYSTEINE; CHRONOTHERAPY; EXPECTORANTS; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SAFROLE; TREATMENT OUTCOME;

EID: 33750125570     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.06.00144905     Document Type: Letter

References (8)

1. Asti C, Melillo G, Caselli GF, et al. Effectiveness of carbocysteine lysine salt monohydrate on models of airway inflammation and hyperresponsiveness. Pharmacol Res 1995; 31: 387-392.
2. Chalumeau M, Cheron G, Assathiany R, et al. Mucolytic agents for acute respiratory tract infections in infants: a pharmacoepidemiologic problem? Arch Pediatr 2002; 9: 1128-1136.
3. Carpagnano GE, Resta O, Foschino-Barbaro MP, et al. Exhaled interleukine-6 and 8-isoprostane in chronic obstructive pulmonary disease: effect of carbocysteine lysine salt monohydrate (SCMC-Lys). Eur J Pharmacol 2004; 505: 169-175.
4. Steventon GB. Diurnal variation in the metabolism of S-carboxymethyl-L-cysteine in man. Drug Metab Dispos 1999; 27: 1092-1097.
5. Pinamonti S, Venturoli L, Leis M, et al. Antioxidant activity of carbocysteine lysine salt monohydrate. Panminerva Med 2001; 43: 215-220.
6. Brandolini L, Allegretti M, Berdini V, et al. Carbocysteine lysine salt monohydrate (SCMC-LYS) is a selective scavenger of reactive oxygen intermediates (ROLs). Eur Cytokine Net 2003; 14: 20-26.
7. Mitchell SC, Waring RH, Haley CS, Idle JR, Smith RL. Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man. Brit J Clin Pharmacol 1984; 18: 507-521.
8. Goreish AH, Bednar S, Jones H, Mitchell SC, Steventon GB. Phenylalanine 4-monooxygenase and the S-oxidation of S-carboxymethyl-L-cysteine. Drug Metab Drug Interact 2004; 20: 159-174.